Negative Pressure Wound Therapy Market Evolving Technology, Segmentation and Industry Analysis 2020 to 2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 27, 2020 (Market Insight Reports) —
Selbyville, Delaware,The latest Negative Pressure Wound Therapy market research added by Market Study Report, LLC, delivers a concise outline regarding the potential factors likely to drive the revenue growth of this industry. The report delivers valuable insights on market revenue, SWOT Analysis, market share, profit estimation and regional landscape of this business vertical. Moreover, the report focuses on significant growth factors and obstacles accepted by market leaders in the Negative Pressure Wound Therapy market.

The global Negative Pressure Wound Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2036.7 million by 2025, from USD 1629 million in 2019.

Request a sample Report of

Read More

Scientists develop new gene therapy for eye disease — ScienceDaily

Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.

The study, which involved a collaboration with clinical teams in the Royal Victoria Eye and Ear Hospital and the Mater Hospital, also has implications for a much wider suite of neurological disorders associated with ageing.

The scientists publish their results today [Thursday 26th November 2020] in leading journal, Frontiers in Neuroscience.

Dominant optic atrophy (DOA)

Characterised by degeneration of the optic nerves, DOA typically starts to cause symptoms in patients in their early adult years. These include moderate vision loss and some colour vision defects, but severity varies, symptoms can worsen over time and some people may become blind. There is currently no way to prevent or cure DOA.

A gene

Read More

Patients who received the combination therapy had increased cognition and functioning — ScienceDaily

UCLA scientists and colleagues found the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.

Researchers say patients using a combination of long-acting antipsychotic medication and a multipronged cognitive remediation that taught memory and problem-solving skills had significant improvements in work and school function.

Schizophrenia is a serious mental illness that affects how a person thinks, feels and behaves. People with schizophrenia may appear to have lost touch with reality, which can cause distress for family and friends and lead to permanent disability. Treatments delivered in a sustained manner can help people with schizophrenia engage in school or work, achieve independence and enjoy personal relationships.

During a 12-month randomized controlled trial, 60 patients from the UCLA Aftercare Program who recently experienced a first episode of schizophrenia were randomized to oral or long-acting injectable antipsychotic medication and to

Read More

Is proton therapy the silver bullet for children with brain cancer? — ScienceDaily

Adelaide is poised to open Australia’s first proton therapy centre in 2025, with children and young adults expected to be the main beneficiaries of more effective cancer treatment with fewer side effects.

But just how safe is proton therapy for children with brain cancer compared to the conventional x-ray radiation delivered post-surgery?

A new study by University of South Australia (UniSA) researchers will explore this question over the next two years, using data from a US hospital to model patient outcomes based on individual cancers, radiosensitivity, sex and age of the children.

UniSA PhD candidate Mikaela Dell’Oro and her supervisors (Dr Michala Short, Dr Puthenparampil Wilson and Prof Eva Bezak) have been awarded $100,000 by the Channel 7 Children’s Research Foundation to lead the project, which will assess the risk of developmental disorders in children as a result of using proton beams to treat paediatric brain tumours.

Compared to conventional

Read More

Individualized brain stimulation therapy improves language performance in stroke survivors — ScienceDaily

Baycrest scientists are pioneering the use of individualized brain stimulation therapy to treat aphasia in recovering stroke patients.

Aphasia is a debilitating language disorder that impacts all forms of verbal communication, including speech, language comprehension, and reading and writing abilities. It affects around one-third of stroke survivors, but can also be present in those with dementia, especially in the form of primary progressive aphasia.

“Aphasia can be very isolating,” says Dr. Jed Meltzer, Baycrest’s Canada Research Chair in Interventional Cognitive Neuroscience and a neurorehabilitation scientist at Baycrest’s Rotman Research Institute (RRI). “It can negatively affect people’s personal relationships, and it often determines whether or not someone can continue working.”

In a recent study published in the journal Scientific Reports, Dr. Meltzer and his team tested language performance and used magnetoencephalography (MEG) to measure brain waves in 11 stroke survivors with aphasia before and after they underwent brain stimulation therapy.

Read More

Researchers show safer, more targeted way to deliver CRISPR gene therapy — ScienceDaily

Light-activated liposomes could help to deliver CRISPR gene therapy — and the method could prove safer and more direct than current methods.

A multi-institutional team involving biomedical engineers and scientists from UNSW Sydney found that liposomes — commonly used in pharmacology to encapsulate drugs or genes — can be triggered by light to release the payload in a specific site of the body.

The team, which reported the findings today in ACS Applied Materials and Interfaces, demonstrated their results in cell lines and animal models, with more research needed to test and confirm their method in humans.

Up until now, CRISPR gene therapy technology, which uses a guide RNA to seek out faulty gene sequences and a Cas9 protein to cut or replace it with healthy versions, has used viruses loaded with the CRISPR molecules that then move through the body to find the targeted cells.

While the technology

Read More

Global Cell Therapy Market and Technology Forecast 2020-2028

Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) — The “Global Cell Therapy – Market and Technology Forecast to 2028” report has been added to’s offering.

The global revenue of the cell therapy market is estimated to be around USD 6 billion in the year 2020 and the market is projected to grow to a value of 9 Billion by the year 2028. The growth momentum for this market segment is accounted to be 6%. This market is segmented as Cell Type, Process and End User.

North America governs the largest segment of the global market, this is due to major research institutes of this field being located in the US like the Institute for Stem Cell Biology, Stanford, and Yale Stem Cell Centre in the US. Canada as well as the U.S, has been providing funds for scientific research in the field of cell therapy which has been driving the

Read More

Italy and the UAE Webinar: COVID-19 – where do we stand with tracing, therapy and a vaccine?

Abu Dhabi, UAE: As part of the InnovItalyUAE initiative, the Embassy of Italy to the UAE, in collaboration with Khalifa University of Science and Technology and the Dubai Future Foundation, will hold a webinar this Wednesday 4 November, with experts from Italy and the UAE exchanging information and experiences in the fight against the pandemic.

The webinar will be divided in three sessions. The first session will be focused on the in-depth study of new therapeutic solutions adopted or under study in the two countries. It will be attended by the renowned Prof. Rino Rappuoli from the Imperial College London and the University of Siena, as well as Head of External Research and Development at GSK Vaccini, and Dr. Habiba Al Safar, Director of the Khalifa University Biotechnology Centre.

The second session is dedicated to the use of tests as a tool to track infections and prevent their spread. Prof.

Read More

Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M

Luke Timmerman interviews Sana Biotechnology CEO Steve Harr at the GeekWire Summit this week.

Sana Biotechnology CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the global biotech industry — detailing its plans to create tools that replace and repair human body cells, with the potential to treat various diseases and create new medicines.

Harr spoke with biotechnology journalist Luke Timmerman, founder of The Timmerman Report, this week at the GeekWire Summit. Sana raised more than $700 million this summer in one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle.

Founded in 2019, the 250-person company has an ambitious goal of both repairing cells in the body (gene therapy) and also replacing damaged cells (cell therapy). It’s led by several former executives from Juno Therapeutics, another Seattle biotech company

Read More

Chip-based technology can create new options for ultrasound therapy with high resolution and intensity

A chip-based technology that generates sound profiles with high resolution and intensity could create new options for ultrasound therapy, which would become more effective and easier.

A team of researchers led by Peer Fischer from the Max Planck Institute for Intelligent Systems and the University of Stuttgart has developed a projector that flexibly modulates three-dimensional ultrasound fields with comparatively little technical effort.

Dynamic sound pressure profiles can thus be generated with higher resolution and sound pressure than the current technology allows. It should soon be easier to tailor ultrasound profiles to individual patients. New medical applications for ultrasound may even emerge.

Ultrasound is widely used as a diagnostic tool in both medicine and materials science. It can also be used therapeutically. In the US, for example, tumors of the uterus and prostate are treated with high-power ultrasound.

The ultrasound destroys the cancer

Read More